Literature DB >> 22249452

[Side effects of tumor pharmacotherapy. What internists should know].

E Wollmer1, A Neubauer.   

Abstract

Cytotoxic drugs have been used in the therapy of malignant tumors for the last 70 years. However, side effects of cytotoxic drugs are very common and often dose-limiting. Although many protocols have been optimized, side effects are still frequently life-threatening. Nausea and vomiting are among the most frequently reported side effects, in addition to mucositis and fatigue. Bone marrow toxicity can lead to neutropenic sepsis, thrombocytopenic bleeding, or anemia with the respective sequelae. In addition to these unspecific side effects, organ toxicity is class or drug specific and may involve the kidney, liver, heart, lung, skin, or central nervous system. As most protocols can be administered on an outpatient basis, knowledge of these side effects is important for the general internist.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22249452     DOI: 10.1007/s00108-011-2930-4

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN: 0020-9554            Impact factor:   0.743


  18 in total

1.  2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer.

Authors:  Walter T Hughes; Donald Armstrong; Gerald P Bodey; Eric J Bow; Arthur E Brown; Thierry Calandra; Ronald Feld; Philip A Pizzo; Kenneth V I Rolston; Jerry L Shenep; Lowell S Young
Journal:  Clin Infect Dis       Date:  2002-02-13       Impact factor: 9.079

2.  Management of skin toxicity associated with cetuximab treatment in combination with chemotherapy or radiotherapy.

Authors:  Carmine Pinto; Carlo Antonio Barone; Giampiero Girolomoni; Elvio Grazioso Russi; Marco Carlo Merlano; Daris Ferrari; Evaristo Maiello
Journal:  Oncologist       Date:  2011-01-27

3.  Travel warning with capecitabine.

Authors:  M Wong; S-P Choo; E-H Tan
Journal:  Ann Oncol       Date:  2009-05-26       Impact factor: 32.976

Review 4.  A systematic review and meta-analysis of intravenous palonosetron in the prevention of chemotherapy-induced nausea and vomiting in adults.

Authors:  Zhou Likun; Jing Xiang; Ba Yi; Duan Xin; Zheng Liu Tao
Journal:  Oncologist       Date:  2011-01-31

5.  Blinded, randomized, multicenter study to evaluate single administration pegfilgrastim once per cycle versus daily filgrastim as an adjunct to chemotherapy in patients with high-risk stage II or stage III/IV breast cancer.

Authors:  F A Holmes; J A O'Shaughnessy; S Vukelja; S E Jones; J Shogan; M Savin; J Glaspy; M Moore; L Meza; I Wiznitzer; T A Neumann; L R Hill; B C Liang
Journal:  J Clin Oncol       Date:  2002-02-01       Impact factor: 44.544

6.  Safety and efficacy of hematopoietic stem cell collection from mobilized peripheral blood in unrelated volunteers: 12 years of single-center experience in 3928 donors.

Authors:  Kristina Hölig; Michael Kramer; Frank Kroschinsky; Martin Bornhäuser; Thilo Mengling; Alexander H Schmidt; Claudia Rutt; Gerhard Ehninger
Journal:  Blood       Date:  2009-08-07       Impact factor: 22.113

7.  Hepcidin induction by transgenic overexpression of Hfe does not require the Hfe cytoplasmic tail, but does require hemojuvelin.

Authors:  Paul J Schmidt; Nancy C Andrews; Mark D Fleming
Journal:  Blood       Date:  2010-09-13       Impact factor: 22.113

8.  Cisplatin-induced peripheral neuropathy. Frequent off-therapy deterioration, demyelinating syndromes, and muscle cramps.

Authors:  T Siegal; N Haim
Journal:  Cancer       Date:  1990-09-15       Impact factor: 6.860

9.  American Society of Clinical Oncology guideline for antiemetics in oncology: update 2006.

Authors:  Mark G Kris; Paul J Hesketh; Mark R Somerfield; Petra Feyer; Rebecca Clark-Snow; James M Koeller; Gary R Morrow; Lawrence W Chinnery; Maurice J Chesney; Richard J Gralla; Steven M Grunberg
Journal:  J Clin Oncol       Date:  2006-05-22       Impact factor: 44.544

10.  Recommended guidelines for the treatment of cancer treatment-induced diarrhea.

Authors:  Al B Benson; Jaffer A Ajani; Robert B Catalano; Constance Engelking; Steven M Kornblau; James A Martenson; Richard McCallum; Edith P Mitchell; Thomas M O'Dorisio; Everett E Vokes; Scott Wadler
Journal:  J Clin Oncol       Date:  2004-07-15       Impact factor: 44.544

View more
  1 in total

1.  The Toxic Effects of Polychemotherapy onto the Liver Are Accelerated by the Upregulated MDR of Lymphosarcoma.

Authors:  Alexandra V Sen'kova; Nadezhda L Mironova; Olga A Patutina; Tatyana A Ageeva; Marina A Zenkova
Journal:  ISRN Oncol       Date:  2012-11-29
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.